Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-059610
Filing Date
2012-11-20
Accepted
2012-11-20 12:31:33
Documents
1
Period of Report
2012-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd360928.html 4  
1 FORM 4 rrd360928.xml 4 4248
  Complete submission text file 0001181431-12-059610.txt   5690
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10445 PACIFIC CENTER CT SAN DIEGO CA 92121
Business Address
GOLD DANIEL P PHD (Reporting) CIK: 0001288233 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50484 | Film No.: 121217190